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beneﬁcial effect could be detected on major adverse cardiac and cerebrovascular event
rates after MSCs infusion 6 months later.
Conclusions: Intracoronary infusion of MSCs does not improve clinical outcome and
cardiac function on MRI-derived parameters.
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Correlation analysis between gene single nucleotide polymorphisms of P2Y12
and coronary heart disease
Zhang Xinxia
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Objectives: To investigate correlation between P2Y12 gene polymorphisms
(rs2046934, rs6787801, rs6798347 and rs6787801) and coronary heart disease.
Methods: 455 patients with coronary artery disease who were diagnosed by coronary
angiography or coronary artery CT angiography and 90 health control individuals
were enrolled in this study. The single nucleotide polymorphisms rs2046934,
rs6787801, rs6798347 and rs6787801 of P2Y12 gene were detected by MassARRAY
Time of Flight Mass Spectrometry. The genotypes and allele frequencies in the two
groups were compared.
Results: Genotypes and frequencies of P2Y12 gene polymorphisms rs2046934 in
coronary heart disease group and control group were as below: CC genotype 2.4%
vs. 4.4%, TT genotype 71.0% vs. 74.4%, CT genotype 26.6% vs. 21.2%; and C allele
frequencies were 2.4% vs. 4.4%, T allele frequencies were 84.3% vs. 85.0%. There
was no signiﬁcant difference between the two groups (P>0.05). Genotypes and
frequencies of P2Y12 gene polymorphisms rs6787801 in coronary heart disease
group and control group were: GG genotype 17.4% vs. 17.8%, AA genotype 36.9%
vs. 31.3%, GA genotype 45.7% vs. 51.1%; and G allele frequencies 40.2% vs.
43.3%; A allele frequencies 59.8% vs. 56.7%. There was no signiﬁcant difference
between these two groups (P>0.05). Genotypes and frequencies of P2Y12 gene
polymorphisms rs6798347 in coronary heart disease group and control group were as
below: AA genotype 9.1% vs. 6.7%, GG genotype 41.6% vs. 52.2%, AG genotype
49.3% vs. 41.1%; and A allele frequencies 29.9% vs. 27.2%, G allele frequencies
70.1% vs. 72.8%. There was no signiﬁcant difference between control group and
coronary heart disease group (P>0.05). Genotypes and frequencies of P2Y12 gene
polymorphisms rs6801273 in coronary heart disease group and control group were as
below: CC genotype 13.4% vs. 10.0%, TT genotype 42.6% vs. 50.0%, CT genotype
44.0% vs. 40.0%; and C allele frequencies 35.4% vs. 30.0%, T allele frequencies
64.6% vs. 70.0%. There was no signiﬁcant difference between the compared groups
(P>0.05).
Conclusions: Single Nucleotide Polymorphisms of P2Y12 gene polymorphisms in
rs2046934, rs6787801, rs6798347 and rs6798347 are not associated with coronary
heart disease.
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Objectives: Vascular endothelial injury caused by hypertension, hyperlipidemia,
hyperglycemia, and other risk factors often lead to vascular endothelial dysfunction,
intimal hyperplasia, chemotaxis of inﬂammatory cytokine secreting cells, and
accumulation of lipid deposits. As a result, coronary atheroscleroticplaque may
occur. Recent studies have suggested that similar to the myocardium and coronary
artery, epicardial adipose tissue (EAT), which is composed of adipocytes, macro-
phages, and monocytes, may produce numerous inﬂammatory cytokines. More
speciﬁcally, inﬂammatory cytokines secreted by EAT contribute to plaque insta-
bility. In this study we investigate how CHD and coronary atheroscleroticplaque
vulnerability are associated with epicardial adipose tissue volume (EATV) and the
inﬂammatory cytokines, matrix metalloproteinase-9 (MMP9) and leptin, derived
from EAT.
Methods: 260 patients were assessed for severity of coronary artery stenosis and
EATV by 64-slice dual-source cardiac computed tomography (CT) scans. These
patients were also screened to determine levels of adipokines in pericardial blood
and insulin resistance indices. Out of the 260 patients, 180 patients were conﬁrmed
to have CHD utilizing digital subtraction angiography (DSA), and the other 80
patients (40 of whom were assessed prior to valve replacement surgery) were
classiﬁed as non-CHD. The vascular remodeling indices and plaque vulnerability
parameters (lipid plaque volume, ﬁbrous plaque volume, and calciﬁed plaque vol-
ume) were measured in order to determine any signiﬁcant correlations with EATV.
Samples of EAT and thoracic adipose tissue (TAT) were collected during the cor-
onary artery bypass graft (CABG) surgery that 40 of the CHD patients received.
Samples were probed for mRNA level and protein level expression of leptin and
MMP9.
Results: (1) The EATVs were signiﬁcantly higher in the CHD group compared to
those of the NCHD group. (2) Subgroup analysis of the CHD patients demon-
strated that EATV in patients with positive remodeling was signiﬁcantly higher
(127.6342.00 cm3 vs. 95.4925.36 cm3) than that of the non-positiveJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Cremodeling group. Lipid plaque volume was positively correlated with EATV (P
¼ 0.04, r¼ 0.07); however, ﬁber plaque volume was negatively correlated with
EATV (P ¼ 0.0077, r¼ -0.06). (3) Logistic regression analysis indicated that
EATV is an independent risk factor for positive vascular remodeling. (4)
Compared to 40 NCHD patients, the 40 CHD patients who received CABG sur-
gery, presented higher levels of mRNA and protein expression of leptin and
MMP9 in EAT (P<0.01). However, there was no signiﬁcant difference (P> 0.05)
in mRNA and protein expression of leptin and MMP9 within the TAT of CHD and
NCHD patients. (5) In the CHD group, leptin and MMP9 levels in EAT and EATV
were positively correlated with lipid plaque volume and ﬁbrous plaque volume
(P<0.05).
Conclusions: Epicardial adipose tissue volume (EATV) and EAT-derived inﬂam-
matory cytokines are signiﬁcantly correlated with plaque vulnerability in coronary
heart disease (CHD). It has been determined that EATV is an independent risk factor
for both CHD and plaque vulnerability. Levels of inﬂammatory cytokines secreted by
EAT and TAT of CHD patients were found to be signiﬁcantly greater than those of
NCHD patients. Levels of inﬂammatory cytokines produced by EAT correlate with
EATVs; therefore, controlling levels EATV and inﬂammation may reduce plaque
vulnerability and decrease the risk of coronary heart disease.
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Dynamic variance of plasma superoxide dismutase (SOD) and malondialdehyde
(MDA) after ischemic postconditioning in patients with acute ST-segment
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Objectives: The dynamic variance of plasma superoxide dismutase (SOD) and
malondialdehyde (MDA) in acute myocardial infarction after ischemic post-
conditioning has not been reported. The present study was to explore the effect of
ischemic postconditioning on plasma superoxide dismutase (SOD) and malondialde-
hyde (MDA) in acute ST-segment elevated myocardial infarction and clinical
signiﬁcance.
Methods: One hundred twenty patients [aged (6016) years; 86% male] of acute
myocardial infarction treated with emergency percutaneous coronary intervention
(PCI) were randomly assigned to a postconditioning or standard protocol. The plasma
SOD and MDA concentrations at 4, 8, 12, 16, 20, 24, 36, and 48 hours after the PCI
were compared respectively, and left ventricular ejection fraction (LVEF), left ven-
tricular end-diastolic volume index (LVEDVI), left ventricular end-systolic volume
index (LVESVI), region wall movement index (RWMI) after the operation for 2
weeks, and occurrence rate of cardiac events after the operation for a year were
compared between two groups.
Results:With similar time-to reperfusion [(16866) minutes in the postconditionging
group vs. (15660) minutes in the standard group, P¼0.56], the plasma SOD values
in the postconditionging group were higher [(115.333.7) ng/ml vs. (90.434.6) ng/
ml, P¼0.011] at 4 h, [(127.3.738.5) ng/ml vs. (95.532.1) ng/ml, P¼0.023] at 8 h,
[(129.243.5) ng/ml vs. (98.634.8) ng/ml, P¼0.021] at 12 h, [(118.337.7) ng/ml
vs. (95.432.6) ng/ml, P¼0.020] at 16 h, [(109.737.5) ng/ml vs. (83.532.8) ng/ml,
P¼0.033] at 20 h, [(117.233.5) ng/ml vs. (89.633.8) ng/ml, P¼0.017] at 24 h,
[(110.334.7) ng/ml vs. (88.434.8) ng/ml, P¼0.031] at 36 h, [(107.3.730.5) ng/ml
vs. (85.530.1) ng/ml, P¼0.043] at 48 h respectively than those in the standard
group. The MDA concentrations in the postconditionging group were lower
[(1.140.44) mmol/l vs. (2.680.66) mmol/l, P¼0.021] at 4 h, [(1.560.47) mmol/l
vs. (3.141.11) mmol/l, P¼0.031]at 8 h, [(1.870.77) mmol/l vs. (4.241.99) mmol/
l, P¼0.021] at 12 h, [(1.770.76) mmol/l vs. (4.011.84) mmol/l, P¼0.018] at 16 h,
[(1.650.65) mmol/l vs. (3.841.76) mmol/l, P¼0.023] at 20 h, [(1.450.47) mmol/l
vs. (3.231.33) mmol/l, P¼0.031] at 24 h, [(1.080.39) mmol/l vs. (2.290.96)
mmol/l, P¼0.044] at 36 h, [(0.780.37) mmol/l vs. (1.740.56) mmol/l, P¼0.043] at
48 h respectively than those in the standard group. After the operation for 2 weeks,
LVEF increased [(50.64.2) % vs. (47.55.3) %, P¼0.011], LVESVI [(31.35.1)
ml/m2 vs. (35.77.2) ml/m2, P¼0.008] and LVEDVI [(57.55.3) ml/m2 vs.
(61.85.9) ml/m2, P¼0.009] and RWMI [(1.510.46) vs. (1.730.52), P¼0.034]
decreased in the postconditionging group compared with the standard group respec-
tively. After the operation for a year, the occurrence rate of cardiac events in the
postconditionging group was signiﬁcantly lower (3.3% vs. 10.3%, P¼0.030] than that
in the standard group.
Conclusions: Ischemic postconditioning can increase plasma SOD concentration and
decrease MDA value between 4 hours and 48 hours after the PCI, and improve cardiac
function, left ventricular remodeling and prognosis in acute ST-segment elevated
myocardial infarction.
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Objectives: The single nucleotide polymorphisms (SNPs) in the FADS1/FADS2
gene cluster have been associated with serum lipid levels and the incidence of
coronary artery disease (CAD), but the results are inconsistent. It is unknown
whether these SNPs in this gene cluster are associated with ischemic stroke (IS).
Therefore, the present study was undertaken to evaluate the associations between
two SNPs (rs174546 and rs174601) and serum lipid levels, as well as the risk of IS
or CAD.
Methods: A total of 534 patients with CAD, 553 patients with IS and 582 healthy
controls were recruited in this study. The patients with is received strict neurological
examination and brain magnetic resonance imaging scan. It was diagnosed according
to the International Classiﬁcation of Diseases (9th Revision). Coronary angiography
was performed in patients with CAD. CAD was deﬁned as signiﬁcant coronary ste-
nosis (> 50%) in at least either one of the three main coronary arteries or their major
branches (branch diameter>2 mm). Subjects with a history of hematologic, neoplastic,
renal, liver, thyroid, autoimmune diseases and type I diabetes mellitus were excluded.
Genotypes of the rs174546 and rs174601 SNPs were determined by Snapshot tech-
nology platform.
Results: The genotype distribution was concordant with the Hardy-Weinberg pro-
portions in both patients and controls. There were signiﬁcant differences in allelic
frequency and genotype distribution between controls and IS or CAD patients
(P<0.05), the TT genotypic frequency of the two SNPs was higher in IS or CAD
patients than in controls (P<0.05). The rs174546 and rs174601 C allele carriers
conferred a reduced risk for IS and CAD (rs174546: OR ¼ 0.62, 95% CI ¼ 0.48-0.80
for IS and OR ¼ 0.57, 95% CI ¼ 0.44-0.75 for CAD; rs174601: OR ¼ 0.61, 95% CI
¼ 0.48-0.79 for IS and OR ¼ 0.54, 95% CI ¼ 0.41-0.70 for CAD; respectively). The
rs174546 SNP was in strong LD with rs174601 (D’ ¼ 0.951; r2 ¼ 0.860). Two
common haplotypes (frequency>3%) derived from the two SNPs accounted for above
90% haplotype variations. Among these two common haplotypes, the haplotype of C-
C (rs174546-rs174601) was also associated with a reduced risk for IS and CAD (OR
¼ 0.76, 95% CI ¼ 0.63-0.91 for IS and OR ¼ 0.72, 95% CI ¼ 0.60-0.87 for CAD;
respectively), whereas the haplotype of T-T (rs174546-rs174601) was associated with
an increased risk for IS and CAD (OR ¼ 1.32, 95% CI ¼ 1.10-1.59 for IS and OR ¼
1.18, 95% CI ¼ 0.98-1.41 for CAD; respectively). There was no signiﬁcant associ-
ation between genotypes and serum lipid levels. There were no signiﬁcant effects of
the rs174546 or rs174601 SNPs on angiographic severity of CAD in different genetic
models (P>0.05).
Conclusions: The present study suggests that the SNPs of rs174546 and rs174601 in
the FADS1/FADS2 gene cluster are associated with the risk of IS or CAD, but not
with serum lipid parameters.
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Objectives: To investigate circulating microRNA (miRNA) expression in apolipo-
protein E (apoE) knockout mice (apoE-/-), and to validate these miRNAs in human
coronary artery disease (CAD).
Methods: Pooled plasma from 10 apoE-/- mice and from 10 healthy C57BL/6 (B6)
mice was used to perform the microarray analysis.
Results: MiR-34a, -21, -23a, -30a, and -106b were differentially expressed in apoE-/-
mice. These expression changes of the miRNAs were conﬁrmed by real-time quan-
titative reverse-transcription PCR (qRT-PCR) in apoE-/- mice. Then, miR-34a, -21,
-23a, -30a, and -106b were detected in the plasma of 32 patients with CAD and of 20
healthy controls. Only miR-34a, -21 and -23a were signiﬁcantly differentially
expressed in the plasma of CAD patients (all P<0.01).
Conclusions: MiRNA34a, miRNA21 and miRNA23a were elevated in CAD patients.
These miRNAs might serve as biomarkers of CAD development and progression.
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Objectives: This study was performed to examine the effect of dobutamine stress real
time three-dimensional echocardiography (DS-RT3DE) on ischemic mitral regurgi-
tation (IMR) secondary to coronary artery disease and to test the hypothesis that IMR
and left ventricular (LV) pump function change differently in different stress state in
patients with coronary artery response.
Methods: DS-RT3DE was performed in 90 consecutive patients with suspected or
known coronary artery disease. Three-dimensional echocardiography was used to
determine the change in left ventricular volume and mitral regurgitation at baseline
and every dobutamine infusion dose (5, 10, 20, 30, 40, 50 mg/kg.min for 3 minutes at
each dose). The LV volume and ejection fraction, LV systolic desynchronization, and
mitral regurgitation color ﬂow Doppler contracta area were quantiﬁed. Patients were
assigned to three groups according to IMR contracta area variation during the stressC118 JACC Vol 64/16/Suppl C j October 16–1procedure, group I included patients who IMR decreased in all stress states, group II
included patients who IMR increased in some states and decreased in other states,
group III included patients who IMR increased in all states.
Results: All patients achieved 20ug/kg$min dose, 82 patients achieved 30ug/kg$min
dose, 64 patients achieved 40ug/kg$min dose, only 39 patients achieved 50ug/kg$min
dose. Atropine was administered in 14 patients (16%). There was no severe adverse
event occurred during the stress procedure in this study. In group I (42 patients), LV
end-diastolic and end-systolic volume decreased and ejection fraction increased with
dobutamine dose increasing, and achieved peak value at 50ug/kg.min dose (P<0.05).
In group II (31 patients), LV end-diastolic and end-systolic volume and ejection
fraction changed same as group I (P<0.05), but the extent less than group I. In group
III (17 patients), LV end-diastolic and end-systolic volume increased and ejection
fraction decreased in low dose (P<0.05), whereas no signiﬁcant change in high dose
(P>0.05). LV synchronism improved in all groups, and group I had better perfor-
mance than other groups (P<0.05).
Conclusions: Dobutamine stress testing, in combination with three-dimensional
echocardiography, is an effective method to obtaining accurate information in the
assessment of the behavior of IMR and LV function. Our study indicates IMR
decreased with LV pump function and synchronisms improving in most patients,
it also suggest that the heart still has considerable hibernate, stunning myocar-
dium. Otherwise, if the IMR keep increase during whole stress procedure, it
proposes the coronary artery has severe stenosis and less viable myocardium.
These ﬁndings may helpful to make up appropriate IMR therapy plan in patients
with ischemic heart disease. We hypotheses only the patients with worsen IMR in
DS-RT3DE need to take mitral valve repair or replacement together with coro-
nary artery bypass grafting operation, and we will try to approve it in future
studies.
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Objectives: Percutaneous coronary intervention (PCI) through transradial approach
(TRA) has shown great effectiveness among unselected patients. However, very few
studies have compared the short and median outcomes between TRA and transfemoral
approach (TFA) for diagnostic angiography or intervention in post-coronary artery
bypass graft (CABG) patients.
Methods: A total of 404 post-CABG patients who referred for graft angiography or
intervention were retrospectively included from June 1, 2006 to April 30, 2011. The
primary endpoint was deﬁned as in-hospital net adverse clinical events (NACE),
which included all-cause death, myocardial infarction, stroke, repeat revascularization
and major bleeding. The secondary endpoint was deﬁned as 1 year major adverse
cardiovascular events (MACE), which included all-cause death, MI or repeat
revascularization.
Results: The incidence rates of the primary endpoint (2.7% vs. 2.7%, P¼1.00) and the
secondary endpoint (11.5% vs. 12%, P¼0.88) were similar between TRA and TFA.
TRA was associated with similar procedure time (33.2325.39 vs. 29.6719.87,
P¼0.18) and contrast volume (157.1189.65 vs. 175.80111.35, P¼0.09) compared
with TFA. Signiﬁcant reduction of access site-related bleeding and post-procedure
stay was detected in the TRA group (P<0.05). In patients who had undergone ad hoc
intervention of the grafts, the contrast volume was higher in the TFA group
(156.0069.70 ml vs. 198.38132.89 ml, P¼0.05). The adjusted rates of in-hospital
NACE and 1 year MACE were similar between TRA and TFA, and TRA was an
independent predictor of BARC2 bleeding.
Conclusions: Compared with TFA, TRA showed the same effectiveness in regard to
the in-hospital and 1 year major outcomes in post-CABG patients undergoing PCI.
TRA was also associated with reduced rate of extra bleeding and length of hospital
stay. For patients undergoing the grafts intervention, the contrast volume was
signiﬁcantly reduced by TRA.
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Objectives: Inﬂammatory response has observed in myocardial infarction (MI).
Rheumatoid arthritis (RA) is a kind of systemic inﬂammatory disease and studies
before have proved MI happened more frequently than general people. This research
had been done to explore the risk factors related to MI in RA patients.9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
